Catheter treatment of hypertrophic obstructive cardiomyopathy

被引:29
作者
Gleichmann, U
Seggewiss, H
Faber, L
Fassbender, D
Schmidt, HK
Strick, S
机构
关键词
SUDDEN-DEATH; VERAPAMIL;
D O I
10.1055/s-2008-1043055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Basic problems and objective: In addition to medication with negative inotropic drugs, surgical myectomy and DDD pacemaker implantation are standard procedures in the treatment of hypertrophic obstructive cardiomyopathy (HOCM). in a preliminary series the results obtained with a recently described method, consisting of transcatheter myocardial reduction, are evaluated. Patients and methods: Six patients (two women, four men; mean age 52.7 [44-68] years), who remained in moderate heart failure despite medical treatment, underwent the procedure. After atrial transseptal puncture (via a catheter introduced percutaneously into the femoral vein) the left ventricular outflow tract (LVOT) gradient was measured at rest and after 5-minute balloon occlusion of the first septal branch of the left coronary artery. After demonstration of significant reduction of the gradient by the occlusion, one (n = 3) or,two (n = 3) septal branches were occluded by the injection of 2-5 ml of 96% alcohol. Results: The LVOT gradient was reduced from 57.8 +/- 22.4 (38-97) mm Hg to 11.3 +/- 8.6 (0-21) mmHg and postextrasystolic from 131.0 +/- 40.7 (78-198) mm Hg to 44.0 +/- 35.6 (19-59) mm Hg. All patients had angina for 24 hours after the procedure. Maximal rise in creatine kinase activity was 982 +/- 589 (392-1729) U/l after 8.0 +/- 3.9 (4-15) hours. In three patients transitory complete atrioventricular block developed 10 min to 5 days later, requiring temporary pacemaker implantation. The further course was without complication in all patients and they were discharged after 7.5 +/- 1.8 (6-11) days. Conclusion: The described catheter method provides a nonsurgical means of reducing the amount of septal myocardium with subsequent reduction of the LVOT gradient in HOCM. Long-term observation in a larger group of patients and comparison with conventional forms of treatment are required to determined the method's ultimate place in the treatment of HOCM.
引用
收藏
页码:679 / 685
页数:7
相关论文
共 28 条
[1]   SURGICAL-TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY WITH SPECIAL REFERENCE TO COMPLICATIONS AND TO ATYPICAL HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY [J].
BIRCKS, W ;
SCHULTE, HD .
EUROPEAN HEART JOURNAL, 1983, 4 :187-190
[2]   TRANSCORONARY CHEMICAL ABLATION OF VENTRICULAR-TACHYCARDIA [J].
BRUGADA, P ;
DESWART, H ;
SMEETS, JLRM ;
WELLENS, HJJ .
CIRCULATION, 1989, 79 (03) :475-482
[3]   IDENTIFICATION OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AT HIGH-RISK FOR SUDDEN-DEATH [J].
CHANG, AC ;
MCAREAVEY, D ;
FANANAPAZIR, L .
CURRENT OPINION IN CARDIOLOGY, 1995, 10 (01) :9-15
[4]   LONG-TERM RESULTS OF DUAL-CHAMBER (DDD) PACING IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY - EVIDENCE FOR PROGRESSIVE SYMPTOMATIC AND HEMODYNAMIC IMPROVEMENT AND REDUCTION OF LEFT-VENTRICULAR HYPERTROPHY [J].
FANANAPAZIR, L ;
EPSTEIN, ND ;
CURIEL, RV ;
PANZA, JA ;
TRIPODI, D ;
MCAREAVEY, D .
CIRCULATION, 1994, 90 (06) :2731-2742
[5]   LONG-TERM MEDICAL-MANAGEMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY [J].
FRANK, MJ ;
ABDULLA, AM ;
CANEDO, MI ;
SAYLORS, RE .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 42 (06) :993-1001
[6]  
Gietzen F., 1994, Z Kardiol, V83, P146
[7]  
HABERER T, 1983, Z KARDIOL, V72, P487
[8]   EFFECTS OF BETA ADRENERGIC BLOCKADE ON CIRCULATION WITH PARTICULAR REFERENCE TO OBSERVATIONS IN PATIENTS WITH HYPERTROPHIC SUBAORTIC STENOSIS [J].
HARRISON, DC ;
GLICK, G ;
CHIDSEY, CA ;
BRAUNWALD, E ;
ROSS, J ;
MASON, DT .
CIRCULATION, 1964, 29 (01) :84-&
[9]   EFFECTS OF DUAL-CHAMBER PACING IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY [J].
JEANRENAUD, X ;
GOY, JJ ;
KAPPENBERGER, L .
LANCET, 1992, 339 (8805) :1318-1323
[10]  
KALTENBACH M, 1979, BRIT HEART J, V42, P35